Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis

Hyperphosphatemia is an important modifiable risk factor for death and cardiovascular events in patients on hemodialysis (HD). As nicotinamide has been shown as an inhibitor of sodium–dependent phosphate co–transport in rat renal tubule and small intestine, we examined whether nicotinamide reduces h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasantha, J., Soundararajan, P., Vanitharani, N., Kannan, G., Thennarasu, P., Neenu, G., Reddy, C. Umamaheswara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193667/
https://www.ncbi.nlm.nih.gov/pubmed/22022084
http://dx.doi.org/10.4103/0971-4065.83735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193667/
https://www.ncbi.nlm.nih.gov/pubmed/22022084
http://dx.doi.org/10.4103/0971-4065.83735

Ejemplares similares